{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T20:43:30Z","timestamp":1794689010690,"version":"4.9.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,15]],"date-time":"2018-02-15T00:00:00Z","timestamp":1518652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Multiple Sclerosis (MuS) is a complex multifactorial neuropathology, resulting in heterogeneous clinical presentation. A very active MuS research field concerns the discovery of biomarkers helpful to make an early and definite diagnosis. The sphingomyelin pathway has emerged as a molecular mechanism involved in MuS, since high levels of ceramides in cerebrospinal fluid (CSF) were related to axonal damage and neuronal dysfunction. Ceramides are the hydrolysis products of sphingomyelins through a reaction catalyzed by a family of enzymes named sphingomyelinases, which were recently related to myelin repair in MuS. Here, using a lipidomic approach, we observed low levels of several sphingomyelins in CSF of MuS patients compared to other inflammatory and non-inflammatory, central or peripheral neurological diseases. Starting by this result, we investigated the sphingomyelinase activity in CSF, showing a significantly higher enzyme activity in MuS. In support of these results we found high number of total exosomes in CSF of MuS patients and a high number of acid sphingomyelinase-enriched exosomes correlated to enzymatic activity and to disease severity. These data are of diagnostic relevance and show, for the first time, high number of acid sphingomyelinase-enriched exosomes in MuS, opening a new window for therapeutic approaches\/targets in the treatment of MuS.<\/jats:p>","DOI":"10.1038\/s41598-018-21497-5","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T11:10:50Z","timestamp":1518174650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":121,"title":["Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1015-3484","authenticated-orcid":false,"given":"Damiana","family":"Pieragostino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Cicalini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lanuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Ercolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"di Ioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Zucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Zappacosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Miscia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marchisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Sacchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Onofrj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-2194","authenticated-orcid":false,"given":"Piero","family":"Del Boccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,15]]},"reference":[{"key":"21497_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of neurology 69, 292\u2013302, https:\/\/doi.org\/10.1002\/ana.22366 (2011).","journal-title":"Annals of neurology"},{"key":"21497_CR2","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1212\/WNL.0b013e3181e3973f","volume":"74","author":"H Tremlett","year":"2010","unstructured":"Tremlett, H., Zhao, Y., Rieckmann, P. & Hutchinson, M. New perspectives in the natural history of multiple sclerosis. Neurology 74, 2004\u20132015, https:\/\/doi.org\/10.1212\/WNL.0b013e3181e3973f (2010).","journal-title":"Neurology"},{"key":"21497_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S1474-4422(13)70233-3","volume":"13","author":"M Comabella","year":"2014","unstructured":"Comabella, M. & Montalban, X. Body fluid biomarkers in multiple sclerosis. The Lancet. Neurology 13, 113\u2013126, https:\/\/doi.org\/10.1016\/S1474-4422(13)70233-3 (2014).","journal-title":"The Lancet. Neurology"},{"key":"21497_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He, X., Huang, Y., Li, B., Gong, C. X. & Schuchman, E. H. Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiology of aging 31, 398\u2013408, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.05.010 (2010).","journal-title":"Neurobiology of aging"},{"key":"21497_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2174\/0929867324666161123093606","volume":"24","author":"M Reale","year":"2017","unstructured":"Reale, M. & Sanchez-Ramon, S. Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis. Current medicinal chemistry 24, 176\u2013192, https:\/\/doi.org\/10.2174\/0929867324666161123093606 (2017).","journal-title":"Current medicinal chemistry"},{"key":"21497_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000315105","volume":"26","author":"S Walter","year":"2010","unstructured":"Walter, S. & Fassbender, K. Spingolipids in Multiple Sclerosis. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 26, 49\u201356, https:\/\/doi.org\/10.1159\/000315105 (2010).","journal-title":"Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"21497_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/1073858409337035","volume":"15","author":"AA Farooqui","year":"2009","unstructured":"Farooqui, A. A. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders. The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry 15, 392\u2013407, https:\/\/doi.org\/10.1177\/1073858409337035 (2009).","journal-title":"The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry"},{"key":"21497_CR8","doi-asserted-by":"publisher","unstructured":"Dargahi, N. et al. Multiple Sclerosis: Immunopathology and Treatment Update. Brain sciences 7, https:\/\/doi.org\/10.3390\/brainsci7070078 (2017).","DOI":"10.3390\/brainsci7070078"},{"key":"21497_CR9","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1093\/brain\/awn190","volume":"131","author":"D Wheeler","year":"2008","unstructured":"Wheeler, D., Bandaru, V. V., Calabresi, P. A., Nath, A. & Haughey, N. J. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain: a journal of neurology 131, 3092\u20133102, https:\/\/doi.org\/10.1093\/brain\/awn190 (2008).","journal-title":"Brain: a journal of neurology"},{"key":"21497_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1007\/BF02531040","volume":"4","author":"EA Moscatelli","year":"1969","unstructured":"Moscatelli, E. A. & Isaacson, E. Gas liquid chromatographic analysis of sphingosine bases in sphingolipids of human normal and multiple sclerosis cerebral white matter. Lipids 4, 550\u2013555 (1969).","journal-title":"Lipids"},{"key":"21497_CR11","doi-asserted-by":"publisher","first-page":"20354","DOI":"10.1074\/jbc.273.32.20354","volume":"273","author":"I Singh","year":"1998","unstructured":"Singh, I., Pahan, K., Khan, M. & Singh, A. K. Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. The Journal of biological chemistry 273, 20354\u201320362 (1998).","journal-title":"The Journal of biological chemistry"},{"key":"21497_CR12","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1093\/brain\/awu139","volume":"137","author":"OG Vidaurre","year":"2014","unstructured":"Vidaurre, O. G. et al. Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics. Brain: a journal of neurology 137, 2271\u20132286, https:\/\/doi.org\/10.1093\/brain\/awu139 (2014).","journal-title":"Brain: a journal of neurology"},{"key":"21497_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s11481-007-9066-2","volume":"2","author":"A Jana","year":"2007","unstructured":"Jana, A. & Pahan, K. Oxidative stress kills human primary oligodendrocytes via neutral sphingomyelinase: implications for multiple sclerosis. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 2, 184\u2013193, https:\/\/doi.org\/10.1007\/s11481-007-9066-2 (2007).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"21497_CR14","doi-asserted-by":"publisher","first-page":"e0178622","DOI":"10.1371\/journal.pone.0178622","volume":"12","author":"M Chami","year":"2017","unstructured":"Chami, M. et al. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination. PloS one 12, e0178622, https:\/\/doi.org\/10.1371\/journal.pone.0178622 (2017).","journal-title":"PloS one"},{"key":"21497_CR15","doi-asserted-by":"publisher","first-page":"e0125597","DOI":"10.1371\/journal.pone.0125597","volume":"10","author":"AN Fonteh","year":"2015","unstructured":"Fonteh, A. N. et al. Sphingolipid metabolism correlates with cerebrospinal fluid Beta amyloid levels in Alzheimer\u2019s disease. PloS one 10, e0125597, https:\/\/doi.org\/10.1371\/journal.pone.0125597 (2015).","journal-title":"PloS one"},{"key":"21497_CR16","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1515\/hsz-2015-0109","volume":"396","author":"J Kornhuber","year":"2015","unstructured":"Kornhuber, J., Rhein, C., Muller, C. P. & Muhle, C. Secretory sphingomyelinase in health and disease. Biological chemistry 396, 707\u2013736, https:\/\/doi.org\/10.1515\/hsz-2015-0109 (2015).","journal-title":"Biological chemistry"},{"key":"21497_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3389\/fneur.2015.00111","volume":"6","author":"T Carandini","year":"2015","unstructured":"Carandini, T. et al. Microvesicles: What is the Role inMultiple Sclerosis? Frontiers in neurology 6, 111, https:\/\/doi.org\/10.3389\/fneur.2015.00111 (2015).","journal-title":"Frontiers in neurology"},{"key":"21497_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1586\/14737175.2014.890893","volume":"14","author":"AD Pusic","year":"2014","unstructured":"Pusic, A. D., Pusic, K. M. & Kraig, R. P. What are exosomes and how can they be used in multiple sclerosis therapy? Expert review of neurotherapeutics 14, 353\u2013355, https:\/\/doi.org\/10.1586\/14737175.2014.890893 (2014).","journal-title":"Expert review of neurotherapeutics"},{"key":"21497_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.23627","volume":"72","author":"C Verderio","year":"2012","unstructured":"Verderio, C. et al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Annals of neurology 72, 610\u2013624, https:\/\/doi.org\/10.1002\/ana.23627 (2012).","journal-title":"Annals of neurology"},{"key":"21497_CR20","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1016\/j.jprot.2011.06.023","volume":"74","author":"P Del Boccio","year":"2011","unstructured":"Del Boccio, P. et al. Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis. Journal of proteomics 74, 2826\u20132836, https:\/\/doi.org\/10.1016\/j.jprot.2011.06.023 (2011).","journal-title":"Journal of proteomics"},{"key":"21497_CR21","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1039\/C4MB00700J","volume":"11","author":"D Pieragostino","year":"2015","unstructured":"Pieragostino, D. et al. An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis. Molecular bioSystems 11, 1563\u20131572, https:\/\/doi.org\/10.1039\/c4mb00700j (2015).","journal-title":"Molecular bioSystems"},{"key":"21497_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.adro.2016.12.005","volume":"2","author":"P Del Boccio","year":"2017","unstructured":"Del Boccio, P. et al. Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study. Advances in radiation oncology 2, 118\u2013124, https:\/\/doi.org\/10.1016\/j.adro.2016.12.005 (2017).","journal-title":"Advances in radiation oncology"},{"key":"21497_CR23","doi-asserted-by":"publisher","first-page":"e62912","DOI":"10.1371\/journal.pone.0062912","volume":"8","author":"C Muhle","year":"2013","unstructured":"Muhle, C. et al. Characterization of acid sphingomyelinase activity in human cerebrospinal fluid. PloS one 8, e62912, https:\/\/doi.org\/10.1371\/journal.pone.0062912 (2013).","journal-title":"PloS one"},{"key":"21497_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.nbd.2003.08.013","volume":"14","author":"AS Paintlia","year":"2003","unstructured":"Paintlia, A. S. et al. Correlation of very long chain fatty acid accumulation and inflammatory disease progression in childhood X-ALD: implications for potential therapies. Neurobiology of disease 14, 425\u2013439 (2003).","journal-title":"Neurobiology of disease"},{"key":"21497_CR25","doi-asserted-by":"publisher","first-page":"e2963","DOI":"10.1038\/cddis.2017.360","volume":"8","author":"A Bai","year":"2017","unstructured":"Bai, A. & Guo, Y. Acid sphingomyelinase mediates human CD4(+) T-cell signaling: potential roles in T-cell responses and diseases. Cell death & disease 8, e2963, https:\/\/doi.org\/10.1038\/cddis.2017.360 (2017).","journal-title":"Cell death & disease"},{"key":"21497_CR26","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.4049\/jimmunol.1400346","volume":"193","author":"A Bai","year":"2014","unstructured":"Bai, A. et al. CD39 and CD161 modulate Th17 responses in Crohn\u2019s disease. Journal of immunology 193, 3366\u20133377, https:\/\/doi.org\/10.4049\/jimmunol.1400346 (2014).","journal-title":"Journal of immunology"},{"key":"21497_CR27","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.4049\/jimmunol.176.4.2397","volume":"176","author":"D Pozo","year":"2006","unstructured":"Pozo, D. et al. CD161 (human NKR-P1A) signaling in NK cells involves the activation of acid sphingomyelinase. Journal of immunology 176, 2397\u20132406 (2006).","journal-title":"Journal of immunology"},{"key":"21497_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.02.002","volume":"306","author":"I Selmaj","year":"2017","unstructured":"Selmaj, I., Mycko, M. P., Raine, C. S. & Selmaj, K. W. The role of exosomes in CNS inflammation and their involvement in multiple sclerosis. Journal of neuroimmunology 306, 1\u201310, https:\/\/doi.org\/10.1016\/j.jneuroim.2017.02.002 (2017).","journal-title":"Journal of neuroimmunology"},{"key":"21497_CR29","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/emboj.2009.45","volume":"28","author":"F Bianco","year":"2009","unstructured":"Bianco, F. et al. Acid sphingomyelinase activity triggers microparticle release from glial cells. The EMBO journal 28, 1043\u20131054, https:\/\/doi.org\/10.1038\/emboj.2009.45 (2009).","journal-title":"The EMBO journal"},{"key":"21497_CR30","doi-asserted-by":"publisher","unstructured":"Galazka, G., Mycko, M. P., Selmaj, I., Raine, C. S. & Selmaj, K. W. Multiple sclerosis: Serum-derived exosomes express myelin proteins. Multiple sclerosis, 1352458517696597, https:\/\/doi.org\/10.1177\/1352458517696597 (2017).","DOI":"10.1177\/1352458517696597"},{"key":"21497_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1002\/ana.24931","volume":"81","author":"I Selmaj","year":"2017","unstructured":"Selmaj, I. et al. Global exosome transcriptome profiling reveals biomarkers for multiple sclerosis. Annals of neurology 81, 703\u2013717, https:\/\/doi.org\/10.1002\/ana.24931 (2017).","journal-title":"Annals of neurology"},{"key":"21497_CR32","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/cyto.a.22010","volume":"81","author":"E Holtom","year":"2012","unstructured":"Holtom, E., Usherwood, J. R., Macey, M. G. & Lawson, C. Microparticle formation after co-culture of human whole blood and umbilical artery in a novel in vitro model of flow. Cytometry. Part A: the journal of the International Society for Analytical Cytology 81, 390\u2013399, https:\/\/doi.org\/10.1002\/cyto.a.22010 (2012).","journal-title":"Cytometry. Part A: the journal of the International Society for Analytical Cytology"},{"key":"21497_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cyto.a.20092","volume":"62","author":"HT Maecker","year":"2004","unstructured":"Maecker, H. T., Frey, T., Nomura, L. E. & Trotter, J. Selecting fluorochrome conjugates for maximum sensitivity. Cytometry. Part A: the journal of the International Society for Analytical Cytology 62, 169\u2013173, https:\/\/doi.org\/10.1002\/cyto.a.20092 (2004).","journal-title":"Cytometry. Part A: the journal of the International Society for Analytical Cytology"},{"key":"21497_CR34","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/leu.2012.122","volume":"26","author":"T Kalina","year":"2012","unstructured":"Kalina, T. et al. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia 26, 1986\u20132010, https:\/\/doi.org\/10.1038\/leu.2012.122 (2012).","journal-title":"Leukemia"},{"key":"21497_CR35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/cyto.a.22071","volume":"81","author":"R Lachmann","year":"2012","unstructured":"Lachmann, R., Lanuti, P. & Miscia, S. OMIP-011: Characterization of circulating endothelial cells (CECs) in peripheral blood. Cytometry. Part A: the journal of the International Society for Analytical Cytology 81, 549\u2013551, https:\/\/doi.org\/10.1002\/cyto.a.22071 (2012).","journal-title":"Cytometry. Part A: the journal of the International Society for Analytical Cytology"},{"key":"21497_CR36","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2007.07.011","volume":"30","author":"S Miscia","year":"2009","unstructured":"Miscia, S. et al. Abeta(1-42) stimulated T cells express P-PKC-delta and P-PKC-zeta in Alzheimer disease. Neurobiology of aging 30, 394\u2013406, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.07.011 (2009).","journal-title":"Neurobiology of aging"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21497-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21497-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:26:58Z","timestamp":1671589618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-21497-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["21497"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-21497-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,15]]},"assertion":[{"value":"19 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3071"}}